Gynecologic, Ovarian, and Cervical Cancer

GYNECOLOGIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Oral Contraceptives Found to Protect Against Ovarian and Endometrial Cancer for up to 35 Years After Discontinuation

Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk.
American Cancer Society Updates Cervical Cancer Screening Guidelines

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline

The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.
Clinical Utility of Deep Phenotyping and Whole-Genome Risk Assessment in Early Cancer Detection and Precision Oncology

State-of-the-art advanced imaging coupled with whole-genome sequencing shows utility in early cancer detection and cancer-associated pathogenic variant detection.
Preclinical Work on Red Blood Cell-Based Therapies in HPV-Positive Solid Tumors Provides Rationale for Clinical Trials in Humans

A microfluidics platform for engineering activated antigen carrier immunotherapies from red blood cells showed promising preliminary results in a mouse model.

GYNECOLOGIC CANCER NEWS

Male doctor explaining results to middlea-ged female patient in hallway

Lynch Syndrome, Recurrence-Free Survival in Endometrial Cancer

April 30, 2021

The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

Adjuvant Therapy Benefit Questioned in POLE-Mutated Endometrial Cancer

April 27, 2021

In women, the association between obesity and endometrial cancer is stronger than in any other type

Peritoneal Cytology Prognostic in Stage II-III Endometrial Cancer

April 23, 2021

Oral bisphosphonates may greatly reduce the risk of endometrial cancer.

Intrauterine Levonorgestrel Showed Activity in Endometrial Adenocarcinoma

April 22, 2021

Although most female patients regain fertility after CHOP-like chemotherapy for aggressive lymphoma,

Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer

April 19, 2021

Next post in Gynecologic Cancer

The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

Adjuvant Therapy Benefit Questioned in POLE-Mutated Endometrial Cancer